Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 96
13
Diseases
10
Unique genes
0.398
Avg. similarity score
Melnick-needles syndrome
Most-connected disease (12 links)
Disease
Searched: Intestinal pseudoobstruction, neuronal
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Intestinal pseudoobstruction, neuronal
Melnick-needles syndrome
Otopalatodigital spectrum disorder
Terminal osseous dysplasia with pigmentary defects
X-linked ehlers-danlos syndrome
X-linked keloid scarring syndrome
Cardiac valvular dysplasia
Congenital idiopathic intestinal pseudoobstruction
Congenital short bowel syndrome
Fg syndrome 2
Frontometaphyseal dysplasia
Intestinal pseudoobstruction, neuronal, chronic idiopathic, x-linked
Otopalatodigital syndrome
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Melnick-needles syndrome | 12 | 12 | 1 |
| Otopalatodigital spectrum disorder | 12 | 12 | 1 |
| Terminal osseous dysplasia with pigmentary defects | 12 | 12 | 1 |
| X-linked ehlers-danlos syndrome | 12 | 12 | 1 |
| X-linked keloid scarring syndrome | 12 | 12 | 1 |
| Cardiac valvular dysplasia | 5 | 5 | 6 |
| Congenital idiopathic intestinal pseudoobstruction | 5 | 5 | 2 |
| Congenital short bowel syndrome | 5 | 5 | 2 |
| Fg syndrome 2 | 5 | 5 | 1 |
| Frontometaphyseal dysplasia | 5 | 5 | 2 |
| Intestinal pseudoobstruction, neuronal | 5 | 5 | 1 |
| Intestinal pseudoobstruction, neuronal, chronic idiopathic, x-linked | 5 | 5 | 1 |
| Otopalatodigital syndrome | 5 | 5 | 2 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| FLNA | 13 / 13 | Cardiac valvular dysplasia, Congenital idiopathic intestinal pseudoobstruction, Congenital short bowel syndrome, Fg syndrome 2 and 9 more |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| GP1b-IX-V activation signalling | Reactome | 2 / 12 | 200× | 4.10e-5 | 9.33e-4 ✓ sig. |
| NF-kappa B signaling pathway | KEGG | 2 / 105 | 22.9× | 3.25e-3 | 2.70e-2 ✓ sig. |
| L1CAM interactions | Reactome | 1 / 4 | 300× | 3.33e-3 | 2.74e-2 ✓ sig. |
| Sensing of DNA Double Strand Breaks | Reactome | 1 / 6 | 200× | 4.99e-3 | 3.64e-2 ✓ sig. |
| Platelet Aggregation (Plug Formation) | Reactome | 1 / 8 | 150× | 6.64e-3 | 4.39e-2 ✓ sig. |
| OAS antiviral response | Reactome | 1 / 9 | 133× | 7.47e-3 | 4.73e-2 ✓ sig. |
| IRAK2 mediated activation of TAK1 complex | Reactome | 1 / 10 | 120× | 8.30e-3 | 5.06e-2 |
| Pexophagy | Reactome | 1 / 10 | 120× | 8.30e-3 | 5.06e-2 |
| Stabilization of p53 | Reactome | 1 / 11 | 109× | 9.12e-3 | 5.37e-2 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | Reactome | 1 / 11 | 109× | 9.12e-3 | 5.37e-2 |
| Alpha-protein kinase 1 signaling pathway | Reactome | 1 / 11 | 109× | 9.12e-3 | 5.37e-2 |
| Platelet Adhesion to exposed collagen | Reactome | 1 / 11 | 109× | 9.12e-3 | 5.37e-2 |
| Cell-extracellular matrix interactions | Reactome | 1 / 12 | 100× | 9.95e-3 | 5.67e-2 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | Reactome | 1 / 12 | 100× | 9.95e-3 | 5.67e-2 |
| Interaction between L1 and Ankyrins | Reactome | 1 / 13 | 92.4× | 1.08e-2 | 5.96e-2 |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| signal transduction in response to DNA damage | GO:0042770 | 2 / 21 | 178× | 5.38e-5 | 1.95e-3 ✓ sig. |
| mitotic spindle assembly | GO:0090307 | 2 / 46 | 81.2× | 2.63e-4 | 6.19e-3 ✓ sig. |
| SCF-dependent proteasomal ubiquitin-dependent protein catabolic process | GO:0031146 | 2 / 61 | 61.3× | 4.64e-4 | 9.05e-3 ✓ sig. |
| collagen fibril organization | GO:0030199 | 2 / 65 | 57.5× | 5.27e-4 | 9.87e-3 ✓ sig. |
| regulation of membrane repolarization during atrial cardiac muscle cell action potential | GO:1905000 | 1 / 1 | 1,869× | 5.35e-4 | 9.88e-3 ✓ sig. |
| regulation of membrane repolarization during cardiac muscle cell action potential | GO:1905031 | 1 / 1 | 1,869× | 5.35e-4 | 9.88e-3 ✓ sig. |
| protein heterotrimerization | GO:0070208 | 1 / 1 | 1,869× | 5.35e-4 | 9.88e-3 ✓ sig. |
| 10-formyltetrahydrofolate biosynthetic process | GO:0009257 | 1 / 2 | 934× | 1.07e-3 | 1.51e-2 ✓ sig. |
| establishment of RNA localization to telomere | GO:0097694 | 1 / 2 | 934× | 1.07e-3 | 1.51e-2 ✓ sig. |
| establishment of protein-containing complex localization to telomere | GO:0097695 | 1 / 2 | 934× | 1.07e-3 | 1.51e-2 ✓ sig. |
| positive regulation of telomerase catalytic core complex assembly | GO:1904884 | 1 / 2 | 934× | 1.07e-3 | 1.51e-2 ✓ sig. |
| purine ribonucleotide biosynthetic process | GO:0009152 | 1 / 2 | 934× | 1.07e-3 | 1.51e-2 ✓ sig. |
| negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation | GO:2000314 | 1 / 2 | 934× | 1.07e-3 | 1.51e-2 ✓ sig. |
| transforming growth factor beta receptor signaling pathway | GO:0007179 | 2 / 112 | 33.4× | 1.55e-3 | 1.87e-2 ✓ sig. |
| cellular response to nitrosative stress | GO:0071500 | 1 / 3 | 623× | 1.60e-3 | 1.88e-2 ✓ sig. |